⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
REGN
Graph AI Raises $13.3M Series A to Scale the First AI-Native Operating System for Patient Safety
prnewswire.com
NVDA
GOOG
MSFT
AMZN
META
IBM
ORCL
CRM
ADBE
INTC
AMD
QCOM
AMAT
MU
SMCI
ASML
LRCX
KLAC
TER
SNPS
CDNS
PANW
CRWD
DDOG
PLTR
SNOW
AI
UPST
SOFI
COIN
RIOT
MARA
PLUG
FCEL
ROKU
NFLX
DIS
CMCSA
TCOM
BABA
JD
PDD
NIO
LI
TSLA
RIVN
LCID
GM
F
STLA
VWAGY
HON
GE
BA
LMT
RTX
GD
NOC
AVAV
KBR
BWXT
XOM
CVX
SHEL
BIDU
NET
FTNT
CSCO
HPQ
DELL
LEN
DHI
NVR
PHM
TMHC
MTH
KBH
BKH
ESNT
MTG
WFG
RGA
AGNC
TWO
PSEC
ARCC
BX
KKR
APO
CME
ICE
MSCI
SPGI
EQIX
AMKR
WDC
SE
MELI
AMGN
GILD
BMY
PFE
MRK
LLY
ABBV
REGN
VRTX
BIIB
AZN
SNY
NVS
ROG
TEVA
BHC
ALKS
IRTC
EXAS
CRIS
EDIT
NTLA
BNTX
MRNA
ALNY
BTAI
NVO
LULU
SIRI
SPOT
PTON
GOOGL
ZS
XPEV
Faruqi & Faruqi, LLP Urges Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Investors to Seek Counsel Before the September 14, 2026 Lead Plaintiff Deadline in the Securities Class Action
prnewswire.com
REGN
$651 Million Aptamers Market Assessment and Outlook, 2032 | Chemical Engineering, Targeted Delivery, and AI-Assisted Discovery are Major Growth Catalysts
globenewswire.com
AGNC
BIIB
REGN
ALNY
CRSP
GILD
AMGN
BMY
MRK
PFE
JNJ
ABBV
LLY
AZN
NVS
SNY
TEVA
BSX
MDLZ
GOOG
MSFT
IBM
NVDA
INTC
AMD
QCOM
AMZN
CRM
ORCL
SAP
ADBE
GOOGL
META
NFLX
DIS
CMCSA
VZ
T
XOM
CVX
KO
PEP
MCD
SBUX
COST
WMT
BABA
JD
BIDU
NTES
PDD
SIRI
AMC
GME
TSLA
NIO
RIVN
LCID
F
GM
STLA
TM
HON
GE
BA
LMT
RTX
GD
CAT
DE
MMM
DOW
DD
LULU
NKE
HD
LOW
SPG
PLD
AMT
EQIX
PLTR
SNOW
DDOG
CRWD
PANW
ZS
FTNT
VRTX
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky to Join Class Action Before September 14, 2026
accessnewswire.com
REGN
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
REGN ALERT: Securities Fraud Class Action Launched Against Regeneron Pharmaceuticals, Inc. - September 14, 2026 Deadline
accessnewswire.com
REGN
REGN MONDAY DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
prnewswire.com
REGN
Pomerantz LLP Updates Investors on Legal Action Brought Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
REGN